Details of the Drug Formulaction

General Information of Drug Formulation (ID: F13556)

• Formulation Name: Methylphenidate 18 mg tablet
• Company: Avera McKennan Hospital

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Methylphenidate	(DM7SJD6)	Attention deficit hyperactivity disorder	6A05.Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Butylated hydroxytoluene	(E00336)	31404	Antioxidant
Ferrosoferric oxide	(E00231)	14789	Colorant
Phosphoric acid	(E00039)	1004	Acidulant; Buffering agent
Propylene glycol	(E00040)	1030	Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Sodium chloride	(E00077)	5234	Diluent; Tonicity agent
Stearic acid	(E00079)	5281	Emulsifying agent; Solubilizing agent; Viscosity-controlling agent; lubricant
Succinic acid	(E00044)	1110	Buffering agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Triacetin	(E00080)	5541	Humectant; Plasticizing agent; Solvent